ACE2 and diabetic kidney disease: While increased activity and expression of ACE2 were reported in early stages of diabetes, downregulation in ACE2 expression has been observed in both pre-clinical studies and in patients with advanced stages of diabetic nephropathy (Tikellis et al., 2003; Reich et al., 2008).